Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/ng.3728

http://scihub22266oqcxt.onion/10.1038/ng.3728
suck pdf from google scholar
C5195898!5195898 !27869830
unlimited free pdf from europmc27869830
    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27869830 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid27869830
      Nat+Genet 2017 ; 49 (1 ): 87-96
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Inactivation of Capicua drives cancer metastasis #MMPMID27869830
  • Okimoto RA ; Breitenbuecher F ; Olivas VR ; Wu W ; Gini B ; Hofree M ; Asthana S ; Hrustanovic G ; Flanagan J ; Tulpule A ; Blakely CM ; Haringsma HJ ; Simmons AD ; Gowen K ; Suh J ; Miller VA ; Ali S ; Schuler M ; Bivona TG
  • Nat Genet 2017[Jan]; 49 (1 ): 87-96 PMID27869830 show ga
  • Metastasis is the leading cause of death in people with lung cancer, yet the molecular effectors underlying tumor dissemination remain poorly defined. Through the development of an in vivo spontaneous lung cancer metastasis model, we show that the developmentally regulated transcriptional repressor Capicua (CIC) suppresses invasion and metastasis. Inactivation of CIC relieves repression of its effector ETV4, driving ETV4-mediated upregulation of MMP24, which is necessary and sufficient for metastasis. Loss of CIC, or an increase in levels of its effectors ETV4 and MMP24, is a biomarker of tumor progression and worse outcomes in people with lung and/or gastric cancer. Our findings reveal CIC as a conserved metastasis suppressor, highlighting new anti-metastatic strategies that could potentially improve patient outcomes.
  • |Adenovirus E1A Proteins/genetics/*metabolism [MESH]
  • |Animals [MESH]
  • |Carcinoma, Non-Small-Cell Lung/genetics/metabolism/*secondary [MESH]
  • |Female [MESH]
  • |Gene Expression Profiling [MESH]
  • |Humans [MESH]
  • |Lung Neoplasms/genetics/metabolism/*pathology [MESH]
  • |Matrix Metalloproteinases, Membrane-Associated/genetics/*metabolism [MESH]
  • |Mice [MESH]
  • |Mice, SCID [MESH]
  • |Proto-Oncogene Proteins c-ets [MESH]
  • |Proto-Oncogene Proteins/genetics/*metabolism [MESH]
  • |Repressor Proteins/*antagonists & inhibitors/genetics/metabolism [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box